Titre : | Addiction, Vol.114, n°6 - June 2019 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/06/2019 |
Année de publication : | 2019 |
Format : | 953-1144 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Addiction Theories and Constructs: a new series [Editorial]. West R., Marsden J., Hastings J., p. 955-956. - Racial discrimination and alcohol use and negative drinking consequences among Black Americans: a meta-analytical review. Desalu J.M., Goodhines P.A., Park A., p. 957-967. - Associations of child and adolescent anxiety with later alcohol use and disorders: a systematic review and meta-analysis of prospective cohort studies. Dyer M.L., Easey K.E., Heron J., Hickman M., Munafo M.R., p. 968-982. - Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: findings from NESARC-III. Simpson T.L., Rise P., Browne K.C., Lehavot K., Kaysen D., p. 983-993. - Forecasting the 2021 local burden of population alcohol-related harms using Bayesian structural time-series. McQuire C., Tilling K., Hickman M., de Vocht F., p. 994-1003. - Is the association between maternal alcohol consumption in pregnancy and pre-school child behavioural and emotional problems causal? Multiple approaches for controlling unmeasured confounding. Lund I.O., Moen Eilertsen E., Gjerde L.C., Roysamb E., Wood M., Reichborn-Kjennerud T., et al., p. 1004-1014. - Increasing potency and price of cannabis in Europe, 2006-16. Freeman T.P., Groshkova T., Cunningham A., Sedefov R., Griffiths P., Lynskey M.T., p. 1015-1023. - Commentary on Freeman et al. (2019): Why does cannabis potency still vary across European countries? Reuter P., p. 1024-1025. - Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings. Cairns R., Schaffer A.L., Ryan N., Pearson S.A., Buckley N.A., p. 1026-1034. - Young adult longitudinal patterns of marijuana use among US National samples of 12th grade frequent marijuana users: a repeated-measures latent class analysis. Terry-McElrath Y.M., O'Malley P.M., Johnston L.D., Schulenberg J.E., p. 1035-1048. - Commentary on Terry-McElrath et al. (2019): Will persistent patterns of youth marijuana use compromise their futures? Green K.M., Arria A.M., p. 1049-1050. - Pharmaceutical payments to physicians may increase prescribing for opioids. Nguyen T.D., Bradford W.D., Simon K.I., p. 1051-1059. - Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC Project. Gravely S., Driezen P., Ouimet J., Quah A.C.K., Cummings K.M., Thompson M.E., et al., p. 1060-1073. - Commentary on Gravely et al (2019): Beginning a new era of nicotine products-beyond the four national-level determinants of nicotine vaping products (NVPs) use. Tabuchi T., p. 1074-1075. - Tobacco control policies and smoking among older adults: a longitudinal analysis of 10 European countries. Serrano-Alarcon M., Kunst A.E., Bosdriesz J.R., Perelman J., p. 1076-1085. - Predictive value of non-consumption outcome measures in alcohol use disorder treatment. Kirouac M., Witkiewitz K., p. 1086-1092. - Commentary on Kirouac & Witkiewitz (2019): A clinical perspective of non-consumption outcomes. Moggi F., p. 1093-1094. - A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study. Yucel M., Oldenhof E., Ahmed S.H., Belin D., Billieux J., Bowden-Jones H., et al., p. 1095-1109. - Identifying core transdisciplinary constructs in addiction has clinical utility. Menchon J.M., p. 1110-1111. - Advancing addiction research through expert consensus. Garavan H., p. 1111-1112. - The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England. Harrison G.I., Murray K., Gore R., Lee P., Sreedharan A., Richardson P., et al., p. 1113-1122. - Addiction Lives: Moira Plant. Berridge V., p. 1123-1127. - Medical marijuana, not miracle marijuana: some well-publicized studies about medical marijuana do not pass a reality check. Caputi T.L., p. 1128-1129. - New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum? Rychert M., Wilkins C., p. 1129-1130. |
Cote : | Abonnement |
Lien : | https://onlinelibrary.wiley.com/toc/13600443/2019/114/6 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
ENGLISH:
AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe.
DESIGN: Repeated cross-sect[...]
Article : Périodique
BACKGROUND AND AIMS: The impact of tobacco control on European older adults has not been studied, despite evidence that smoking cessation at old age can bring significant life expectancy gains. Our aim was to evaluate the impact of tobacco contr[...]
Article : Périodique
BACKGROUND AND AIMS: Long-term frequent marijuana use is associated with significant negative outcomes, yet little is known about the longitudinal course of marijuana use among those who start frequent use during adolescence. Objectives are (a) [...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil